Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy. [PDF]
Chwalenia K, Wood MJA, Roberts TC.
europepmc +1 more source
MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
Jan Trøst Jørgensen +2 more
openalex +1 more source
Protocol for using MYOD1-transduced human urine-derived cells as a predictive platform for exon skipping therapy in Duchenne muscular dystrophy. [PDF]
Kunitake K +4 more
europepmc +1 more source
Additional file 3: of Elusive sources of variability of dystrophin rescue by exon skipping
Maria Candida Vila +19 more
openalex +1 more source
Novel FBN1 intron variant causes isolated ectopia lentis via in-frame exon skipping. [PDF]
Shimizu N +8 more
europepmc +1 more source
30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon Skipping. [PDF]
Matsuo M.
europepmc +1 more source
The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping
Thomas van Overeem Hansen +5 more
openalex +2 more sources
Optimization of Exon-Skipping Riboswitches and Their Applications to Control Mammalian Cell Fate. [PDF]
Nomura Y +5 more
europepmc +1 more source
Case Report: a novel variant in <i>WT1</i> leads to focal segmental glomerulosclerosis and uterovaginal anomalies through exon skipping. [PDF]
Marquez J +6 more
europepmc +1 more source

